About this Research Topic
Esophageal cancer continues to be a significant global health burden, leading to numerous cancer-related deaths each year. Recent strides have been made particularly in the realm of treating locally advanced esophageal squamous cell carcinoma, including improvements in surgical techniques and neoadjuvant therapies. Yet, as the medical community ventures into the immunotherapy era, several contentious issues remain unresolved. Debates rage over the optimal neoadjuvant treatments and the utilization of immunotherapy as postoperative adjuvant therapy, alongside burgeoning interests in identifying biomarkers for prognostication and complications, and the adoption of enhanced recovery protocols post-surgery.
This Research Topic aims to illuminate the recent progress and continuing hurdles in the surgical treatment and overall management of esophageal cancer. By providing a detailed exploration of current treatment guidelines, recent advancements, and predominant theories in the field, this research endeavors to offer a comprehensive overview of the present state of esophageal cancer management. The goal is to draw together insightful analyses and reviews that can inform future research directions and improve patient care outcomes.
To gather further insights in the evolving terrain of esophageal cancer treatment, we welcome articles addressing, but not limited to, the following themes:
•Exploration of neoadjuvant immunotherapy for locally advanced esophageal cancer;
•Whole course management of esophageal cancer treatment;
•Selection of subsequent treatment regimens;
•Current Surgical Management of esophageal cancer;
•Palliative Options for Advanced esophageal cancer;
•Organ Preservation in esophageal cancer.
This Research Topic aims to illuminate the recent progress and continuing hurdles in the surgical treatment and overall management of esophageal cancer. By providing a detailed exploration of current treatment guidelines, recent advancements, and predominant theories in the field, this research endeavors to offer a comprehensive overview of the present state of esophageal cancer management. The goal is to draw together insightful analyses and reviews that can inform future research directions and improve patient care outcomes.
To gather further insights in the evolving terrain of esophageal cancer treatment, we welcome articles addressing, but not limited to, the following themes:
•Exploration of neoadjuvant immunotherapy for locally advanced esophageal cancer;
•Whole course management of esophageal cancer treatment;
•Selection of subsequent treatment regimens;
•Current Surgical Management of esophageal cancer;
•Palliative Options for Advanced esophageal cancer;
•Organ Preservation in esophageal cancer.
Keywords: esophageal cancer, surgery, diagnosis, comprehensive treatment MDT
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
